Diagnostics

Verséa Diagnostics, a division of Verséa Holdings, Inc., in partnership with nVision Medical Supply Solutions, brings innovative point of care and lab-based diagnostic solutions to healthcare providers and patients. The Versea model of partnerships and licensing of high utility diagnostic tests gives us the flexibility to adapt quickly to existing and future market needs and provide our customers with the market’s best options from a single-source partner. The team has a model centered around ongoing education from clinician to clinician, an ability to provide expanded clinical studies through Clinical Research Organizations (CRO’s) as well as non-personal branding and awareness campaigns for all the partner manufacturers and R&D alliances.

Diversified Portfolio

The portfolio is continually expanding to provide high quality diagnostic solutions across a wide range of testing segments including:

DIAGNOSTICS

Drug Diagnostics Multi-panel qualitative testing

DIAGNOSTICS

Infection Control Single and multi-pathogen

DIAGNOSTICS

Biomarkers Inflammatory Biomarkers

Versea. Provides to bulk tests for Drug Screening, Infection Detection including COVID-19, Biomarker and Molecular to hospitals, private practices, urgent care clinics, pharmacies and other healthcare segments across the United States and internationally. Versea is able to assist with product registrations and distribution into healthcare provider segments outside of the United States including:

Diagnostics

Versea Team of experts continues to research and identify the highest quality tests that are made to the highest standards. All the testing offered is FDA Approved or Emergency Use Authorized (EUA).

Do you want to receive more information about our testing options?